StockNews.com started coverage on shares of Streamline Health Solutions (NASDAQ:STRM – Free Report) in a research note released on Friday morning. The firm issued a sell rating on the stock.
Separately, Craig Hallum upgraded shares of Streamline Health Solutions to a “strong-buy” rating in a report on Thursday, September 5th.
Read Our Latest Stock Report on STRM
Streamline Health Solutions Stock Down 3.1 %
Streamline Health Solutions (NASDAQ:STRM – Get Free Report) last announced its quarterly earnings data on Wednesday, September 11th. The company reported ($0.75) earnings per share for the quarter, missing the consensus estimate of ($0.60) by ($0.15). The company had revenue of $4.48 million during the quarter. Streamline Health Solutions had a negative net margin of 92.72% and a negative return on equity of 44.85%.
About Streamline Health Solutions
Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.
Featured Stories
- Five stocks we like better than Streamline Health Solutions
- ESG Stocks, What Investors Should Know
- Real Estate Sector Outperforms: 3 Stocks to Gain Exposure
- How to invest in marijuana stocks in 7 stepsĀ
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- Best Stocks Under $5.00
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
Receive News & Ratings for Streamline Health Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Streamline Health Solutions and related companies with MarketBeat.com's FREE daily email newsletter.